Erin Whaley, a partner in Troutman Pepper Locke’s Health Care + Life Sciences Practice Group, was quoted in the February 27, 2025 article, “Companies Bring AI Agents to Healthcare.”

AI software can be subject to Food and Drug Administration regulation depending on what it does, said Erin Whaley, a partner with law firm Troutman Pepper Locke. The more autonomous it is intended to be and the higher the risk it poses, the more likely it is to be regulated, she added.

Insight Industries + Practices